• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎感染和肝细胞癌中 CD8 T 细胞耗竭的遗传和表型差异。

Genetic and phenotypic difference in CD8 T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma.

机构信息

Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

Liver Transplantation Center of the First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

出版信息

J Med Genet. 2019 Jan;56(1):18-21. doi: 10.1136/jmedgenet-2018-105267. Epub 2018 Apr 17.

DOI:10.1136/jmedgenet-2018-105267
PMID:29666149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6327916/
Abstract

BACKGROUND

Several recent studies published have suggested that T cell exhaustion exists both in chronic infection and cancer. However, to date, few studies have investigated their differences. Here we designed this study to explore the genetic and phenotypic difference in CD8 T cell exhaustion between chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC).

METHODS

In this study, we assayed the phenotypes and functional states of CD8 T cells separating from human CHB tissues and HCC tissues, and re-analyse the single-cell sequencing data (GSE98638) published previously. Clustering analysis of genes was performed using the T cell exhaustion gene modules (modules 1-4) proposed by Speiser.

RESULTS

CD8 T cells from liver tissues of both CHB and HCC showed high levels of exhaustion markers, DOI: programmed cell death-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), and lymphocyte-activation gene 3 (LAG-3), decreased proliferation (Ki67) and cell activity (CD69), and reduced production of effector cytokines (interferon-γ, interleukin-2 and tumour necrosis factor-α). Compared with CD8 T cells from CHB tissues, those from HCC tissue showed higher expression levels of exhaustion markers, lower levels of proliferation, cell activity and the production of effector cytokines. Cluster analysis showed that exhaustion associated genes in CHB and HCC are inclined to distribute into modules 3 while those isolated from HCC into modules 1 and 2.

CONCLUSIONS

CD8 T cell exhaustion existed both in CHB and HCC, but the phenotypes, functional states and underlying mechanisms are somewhat different between the two.

摘要

背景

最近发表的几项研究表明,T 细胞耗竭既存在于慢性感染中,也存在于癌症中。然而,迄今为止,很少有研究调查它们之间的差异。在这里,我们设计了这项研究,以探讨慢性乙型肝炎 (CHB) 和肝细胞癌 (HCC) 中 CD8 T 细胞耗竭在遗传和表型上的差异。

方法

在这项研究中,我们检测了从人 CHB 组织和 HCC 组织中分离出的 CD8 T 细胞的表型和功能状态,并重新分析了先前发表的单细胞测序数据 (GSE98638)。使用 Speiser 提出的 T 细胞耗竭基因模块 (模块 1-4) 对基因进行聚类分析。

结果

CHB 和 HCC 肝组织中的 CD8 T 细胞表现出高水平的耗竭标志物,包括程序性细胞死亡蛋白 1 (PD-1)、T 细胞免疫球蛋白和粘蛋白结构域 3 (TIM-3)、细胞毒性 T 淋巴细胞相关抗原 4 (CTLA-4) 和淋巴细胞激活基因 3 (LAG-3),增殖 (Ki67) 和细胞活性 (CD69) 降低,效应细胞因子 (干扰素-γ、白细胞介素-2 和肿瘤坏死因子-α) 的产生减少。与 CHB 组织中的 CD8 T 细胞相比,HCC 组织中的 CD8 T 细胞表现出更高的耗竭标志物表达水平、更低的增殖、细胞活性和效应细胞因子产生水平。聚类分析表明,CHB 和 HCC 中与耗竭相关的基因倾向于分布在模块 3 中,而从 HCC 中分离出的基因则分布在模块 1 和 2 中。

结论

CD8 T 细胞耗竭既存在于 CHB 中,也存在于 HCC 中,但两者之间的表型、功能状态和潜在机制有所不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/6327916/7086e41f5070/jmedgenet-2018-105267f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/6327916/a974badc4cf5/jmedgenet-2018-105267f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/6327916/7086e41f5070/jmedgenet-2018-105267f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/6327916/a974badc4cf5/jmedgenet-2018-105267f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6ff/6327916/7086e41f5070/jmedgenet-2018-105267f02.jpg

相似文献

1
Genetic and phenotypic difference in CD8 T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma.慢性乙型肝炎感染和肝细胞癌中 CD8 T 细胞耗竭的遗传和表型差异。
J Med Genet. 2019 Jan;56(1):18-21. doi: 10.1136/jmedgenet-2018-105267. Epub 2018 Apr 17.
2
PD1 CD8 T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma.PD1 CD8 T 细胞与肝癌衰竭特征和不良临床结局相关。
J Immunother Cancer. 2019 Nov 29;7(1):331. doi: 10.1186/s40425-019-0814-7.
3
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8 T Cells and Features of Hepatocellular Carcinoma.肿瘤浸润 CD8 T 细胞中 PD1 的表达水平与肝细胞癌特征的关系。
Gastroenterology. 2018 Dec;155(6):1936-1950.e17. doi: 10.1053/j.gastro.2018.08.030. Epub 2018 Aug 24.
4
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 regulatory B cell expansion.肿瘤来源的外泌体 HMGB1 通过促进 TIM-1 调节性 B 细胞扩增促进肝细胞癌免疫逃逸。
J Immunother Cancer. 2018 Dec 10;6(1):145. doi: 10.1186/s40425-018-0451-6.
5
Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.阻断Tim-3或/和PD-1可逆转HBV相关肝细胞癌中肿瘤浸润淋巴细胞的功能障碍。
Bull Cancer. 2018 May;105(5):493-501. doi: 10.1016/j.bulcan.2018.01.018. Epub 2018 Mar 22.
6
T cell dysfunction in chronic hepatitis B infection and liver cancer: evidence from transcriptome analysis.慢性乙型肝炎感染和肝癌中 T 细胞功能障碍:来自转录组分析的证据。
J Med Genet. 2019 Jan;56(1):22-28. doi: 10.1136/jmedgenet-2018-105570. Epub 2018 Dec 5.
7
Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma.白细胞介素 22 与肝细胞癌的发生发展及预后不良相关。
Clin Res Hepatol Gastroenterol. 2020 Nov;44(6):855-864. doi: 10.1016/j.clinre.2020.01.009. Epub 2020 Mar 20.
8
High expression of circulating exosomal PD-L1 contributes to immune escape of hepatocellular carcinoma and immune clearance of chronic hepatitis B.循环外泌体 PD-L1 的高表达有助于肝癌的免疫逃逸和慢性乙型肝炎的免疫清除。
Aging (Albany NY). 2024 Jul 17;16(14):11373-11384. doi: 10.18632/aging.206020.
9
Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.免疫细胞在乙型肝炎相关肝细胞癌手术切除后的预后作用取决于其定位和肿瘤大小。
J Immunother. 2016 Jan;39(1):36-44. doi: 10.1097/CJI.0000000000000104.
10
Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.用于肝细胞癌和病毒性肝炎的特异性CD8(+) T细胞应答免疫疗法。
World J Gastroenterol. 2016 Jul 28;22(28):6469-83. doi: 10.3748/wjg.v22.i28.6469.

引用本文的文献

1
Mitochondria-related parameters of lymphocyte subsets can distinguish different disease stages in patients with HBV infection.淋巴细胞亚群的线粒体相关参数可区分HBV感染患者的不同疾病阶段。
Sci Rep. 2025 Jul 1;15(1):21008. doi: 10.1038/s41598-025-05922-0.
2
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.肿瘤相关巨噬细胞和 CD8+ T 细胞:HBV 相关 HCC 发病机制中的双重作用者。
Front Immunol. 2024 Oct 10;15:1472430. doi: 10.3389/fimmu.2024.1472430. eCollection 2024.
3
Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression.

本文引用的文献

1
Emerging targets in cancer immunotherapy.癌症免疫疗法中的新兴靶点。
Semin Cancer Biol. 2018 Oct;52(Pt 2):39-52. doi: 10.1016/j.semcancer.2017.10.001. Epub 2017 Oct 5.
2
The pros and cons of dying tumour cells in adaptive immune responses.适应性免疫反应中垂死肿瘤细胞的利弊。
Nat Rev Immunol. 2017 Sep;17(9):591. doi: 10.1038/nri.2017.87. Epub 2017 Jul 31.
3
The importance of immunization in cancer prevention, treatment, and survivorship.免疫接种在癌症预防、治疗和生存中的重要性。
慢性乙型肝炎免疫耗竭的研究进展:检查点受体表达综述
Pharmaceuticals (Basel). 2024 Jul 21;17(7):964. doi: 10.3390/ph17070964.
4
Harnessing CD8 T cell dynamics in hepatitis B virus-associated liver diseases: Insights, therapies and future directions.利用乙型肝炎病毒相关肝脏疾病中的 CD8 T 细胞动力学:见解、疗法和未来方向。
Clin Transl Med. 2024 Jul;14(7):e1731. doi: 10.1002/ctm2.1731.
5
New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.肝癌中 T 细胞耗竭的新见解:从机制到治疗。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12543-12560. doi: 10.1007/s00432-023-05083-5. Epub 2023 Jul 9.
6
The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection.CTLA-4 在慢性乙型肝炎病毒感染中 T 细胞耗竭的作用。
Viruses. 2023 May 10;15(5):1141. doi: 10.3390/v15051141.
7
Screening and Identification of HBV Epitopes Restricted by Multiple Prevalent HLA-A Allotypes.HBV 表位的多重流行 HLA-A 同种型限制的筛选和鉴定。
Front Immunol. 2022 Apr 7;13:847105. doi: 10.3389/fimmu.2022.847105. eCollection 2022.
8
A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus.对从乙型肝炎病毒蛋白质组中确定的T细胞表位的系统评价
Vaccines (Basel). 2022 Feb 8;10(2):257. doi: 10.3390/vaccines10020257.
9
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.解析肝细胞癌(HCC)中的肿瘤异质性——多组学和单细胞组学方法。
Semin Liver Dis. 2021 Jan;41(1):9-18. doi: 10.1055/s-0040-1722261. Epub 2021 Jan 14.
10
The application of single-cell sequencing technology in the diagnosis and treatment of hepatocellular carcinoma.单细胞测序技术在肝细胞癌诊断与治疗中的应用
Ann Transl Med. 2019 Dec;7(23):790. doi: 10.21037/atm.2019.11.116.
CA Cancer J Clin. 2017 Sep;67(5):398-410. doi: 10.3322/caac.21407. Epub 2017 Jul 28.
4
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.针对免疫检查点分子的抗体恢复了肝癌浸润 T 细胞的功能。
Gastroenterology. 2017 Oct;153(4):1107-1119.e10. doi: 10.1053/j.gastro.2017.06.017. Epub 2017 Jun 23.
5
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.单细胞测序揭示肝癌浸润 T 细胞景观。
Cell. 2017 Jun 15;169(7):1342-1356.e16. doi: 10.1016/j.cell.2017.05.035.
6
Engineered T cells: the promise and challenges of cancer immunotherapy.工程化T细胞:癌症免疫疗法的前景与挑战
Nat Rev Cancer. 2016 Aug 23;16(9):566-81. doi: 10.1038/nrc.2016.97.
7
Regulatory circuits of T cell function in cancer.肿瘤微环境中 T 细胞功能的调控回路。
Nat Rev Immunol. 2016 Oct;16(10):599-611. doi: 10.1038/nri.2016.80. Epub 2016 Aug 16.
8
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.慢性乙型肝炎中乙型肝炎病毒特异性及全身性T细胞功能障碍
Gastroenterology. 2016 Mar;150(3):684-695.e5. doi: 10.1053/j.gastro.2015.11.050. Epub 2015 Dec 10.
9
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.使用DESeq2对RNA测序数据的倍数变化和离散度进行适度估计。
Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
10
Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.丙型肝炎病毒削弱干扰素诱导的主要组织相容性复合体 I 表达,并降低 CD8+T 细胞效应功能。
Gastroenterology. 2014 May;146(5):1351-60.e1-4. doi: 10.1053/j.gastro.2014.01.054. Epub 2014 Jan 31.